This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
Leukemia Open Access 09 February 2016
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Baskaran, R. et al. Nature 387, 516–519 (1997).
Shafman, T. et al. Nature 387, 520–523 (1997).
Zakian, V. A. Cell 82, 685–687 (1995).
Savitsky, K. et al. Hum. Mol. Genet. 4, 2025–2032 (1995).
Hartley, K. O. et al. Cell 82, 849–856 (1995).
Xu, Y. & Baltimore, D. Genes Dev. 10, 2401–2410 (1996).
Baskaran, R., Chiang, G. C. & Wang, J. Y. Mol. Cell Biol. 16, 3361–3369 (1996).
Kharbanda, S. et al. Nature 376, 785–788 (1995).
Yuan, Z. M. et al. Nature 382, 272–274 (1996).
Anderson, C. W. & Carter, T. H. Curr. Top. Microbiol. Imrnunol. 217, 91–111 (1996).
Welch, P. J. & Wang, J. Y. Cell 75, 779–790 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brown, L., McCarthy, N. A sense-abl response?. Nature 387, 450–451 (1997). https://doi.org/10.1038/387450a0
Issue Date:
DOI: https://doi.org/10.1038/387450a0
This article is cited by
-
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors
Medical Oncology (2018)
-
Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy
Breast Cancer (2017)
-
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
Leukemia (2016)
-
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
Nature Medicine (2014)
-
A small molecule Abl kinase inhibitor induces differentiation of Abelson virus–transformed pre-B cell lines
Nature Immunology (2003)